» Articles » PMID: 29200851

Magnetic Hydroxyapatite: a Promising Multifunctional Platform for Nanomedicine Application

Overview
Publisher Dove Medical Press
Specialty Biotechnology
Date 2017 Dec 5
PMID 29200851
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

In this review, specific attention is paid to the development of nanostructured magnetic hydroxyapatite (MHAp) and its potential application in controlled drug/gene delivery, tissue engineering, magnetic hyperthermia treatment, and the development of contrast agents for magnetic resonance imaging. Both magnetite and hydroxyapatite materials have excellent prospects in nanomedicine with multifunctional therapeutic approaches. To date, many research articles have focused on biomedical applications of nanomaterials because of which it is very difficult to focus on any particular type of nanomaterial. This study is possibly the first effort to emphasize on the comprehensive assessment of MHAp nanostructures for biomedical applications supported with very recent experimental studies. From basic concepts to the real-life applications, the relevant characteristics of magnetic biomaterials are patented which are briefly discussed. The potential therapeutic and diagnostic ability of MHAp-nanostructured materials make them an ideal platform for future nanomedicine. We hope that this advanced review will provide a better understanding of MHAp and its important features to utilize it as a promising material for multifunctional biomedical applications.

Citing Articles

Application of Nanohydroxyapatite in Medicine-A Narrative Review.

Lubojanski A, Zakrzewski W, Samol K, Bieszczad-Czaja M, Switala M, Wiglusz R Molecules. 2024; 29(23.

PMID: 39683785 PMC: 11643452. DOI: 10.3390/molecules29235628.


Evaluation of magnetic hyperthermia, drug delivery and biocompatibility (bone cell adhesion and zebrafish assays) of trace element co-doped hydroxyapatite combined with Mn-Zn ferrite for bone tissue applications.

Tithito T, Sillapaprayoon S, Chantho V, Pimtong W, Thongbunchoo J, Charoenphandhu N RSC Adv. 2024; 14(40):29242-29253.

PMID: 39285891 PMC: 11404014. DOI: 10.1039/d4ra03867c.


Magnetic Hydroxyapatite Nanoparticles in Regenerative Medicine and Nanomedicine.

Inam H, Sprio S, Tavoni M, Abbas Z, Pupilli F, Tampieri A Int J Mol Sci. 2024; 25(5).

PMID: 38474056 PMC: 10932331. DOI: 10.3390/ijms25052809.


Antibiotic photocatalysis and antimicrobial activity of low-cost multifunctional FeO@HAp nanocomposites.

Labrag J, Abbadi M, Hnini M, Bekkali C, Bouziani A, Robert D J Environ Health Sci Eng. 2023; 21(2):429-440.

PMID: 37869605 PMC: 10584758. DOI: 10.1007/s40201-023-00869-8.


Bio-Inspired Nanomaterials for Micro/Nanodevices: A New Era in Biomedical Applications.

Harun-Ur-Rashid M, Jahan I, Foyez T, Imran A Micromachines (Basel). 2023; 14(9).

PMID: 37763949 PMC: 10536921. DOI: 10.3390/mi14091786.


References
1.
Zhu Y, Yang Q, Yang M, Zhan X, Lan F, He J . Protein Corona of Magnetic Hydroxyapatite Scaffold Improves Cell Proliferation via Activation of Mitogen-Activated Protein Kinase Signaling Pathway. ACS Nano. 2017; 11(4):3690-3704. DOI: 10.1021/acsnano.6b08193. View

2.
Elsherbini A, Saber M, Aggag M, El-Shahawy A, Shokier H . Laser and radiofrequency-induced hyperthermia treatment via gold-coated magnetic nanocomposites. Int J Nanomedicine. 2011; 6:2155-65. PMC: 3215156. DOI: 10.2147/IJN.S23952. View

3.
Kumar A, Nune K, Basu B, Misra R . Mechanistic contribution of electroconductive hydroxyapatite-titanium disilicide composite on the alignment and proliferation of cells. J Biomater Appl. 2016; 30(10):1505-16. DOI: 10.1177/0885328216631670. View

4.
Padwal P, Bandyopadhyaya R, Mehra S . Polyacrylic acid-coated iron oxide nanoparticles for targeting drug resistance in mycobacteria. Langmuir. 2014; 30(50):15266-76. DOI: 10.1021/la503808d. View

5.
Abbasi Aval N, Islamian J, Hatamian M, Arabfirouzjaei M, Javadpour J, Rashidi M . Doxorubicin loaded large-pore mesoporous hydroxyapatite coated superparamagnetic Fe3O4 nanoparticles for cancer treatment. Int J Pharm. 2016; 509(1-2):159-167. DOI: 10.1016/j.ijpharm.2016.05.046. View